Clinilabs Drug Development Corporation, the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development, was engaged by a large, clinical-stage biopharmaceutical company to manage a randomized, double-blind, placebo-controlled study of a therapy for patients with acute migraine headache. The pivotal trial, involving 100 sites, various demographics and [...]

Clinilabs Drug Development Corporation, a mid-sized, full-service CRO that provides a full range of clinical drug development services, has been utilizing Facebook advertising as an essential tool for generating study participant leads with good success. In fact, Facebook recruitment has been one of Clinilabs’ fastest responding and lowest cost recruitment tools. But even with the [...]

Clinilabs Drug Development Corporation, a CNS-focused contract research organization, and SureClinical, a global provider of innovative cloud solutions for the health sciences market, are sponsoring a global Lunch & Learn series demonstrating how sponsors can streamline and accelerate the clinical trials process. Focusing on real-world examples, Clinilabs will reveal strategies that cut their site initiation [...]

Clinilabs Drug Development Corporation is pleased to announce that it has established a 6-bed epilepsy monitoring unit at its New York City facility. The facility, which boasts a 50-bed inpatient capacity for clinical studies, offers sponsors and subjects six comfortable, private rooms for video EEG monitoring. Each room is equipped with premium bedding, with beds [...]

At this year’s CNS Summit, held in Boca Raton, Florida November 1 – 4 2017, attendees participated in a panel discussion that considered the characteristics that investigator sites will have in the future.  Many of the panelists contemplated the role that digital technology might have on the way that clinical trial sites will function. It [...]